Ignite Creation Date:
2024-05-06 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05947448
Status:
RECRUITING
Last Update Posted:
2024-04-01
First Post:
2023-07-07
Brief Title:
Efficacy and Safety of Mexartan Potassium Tablets AZL-M and Calcium Channel Blockers CCB in the Treatment of Adults With Essential Hypertension in Chinese Population a National Multicenter Prospective Observational Study
Sponsor:
Hasten Biopharmaceutical Co Ltd
Organization:
Hasten Biopharmaceutical Co Ltd
Organization Data
Organization:
Hasten Biopharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
Ph4-HST-EDA-C-NIS-22-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hasten Biopharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None